4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-15-075194
Chief Financial Officer acquired 7,478 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Ruffo Frank · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2015-10-13 | Conversion : show line 1 in the form | +7,478 | 137,912 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2015-10-13 | Conversion : show line 2 in the form Series A Preferred Stock | −20,000 | 0 | D |
| 2015-10-13 | Conversion : show line 3 in the form Series B Preferred Stock | −5,802 | 0 | D |
Loading xslF345X03/doc4.xml…